Introduction to Mounjaro and Wegovy
In the search for effective weight-loss solutions, two names come up again and again: Mounjaro and Wegovy. Both are approved by the EMA and have shown promising results in clinical trials. This guide looks at how each works, their benefits and side effects, and real user experiences to help you understand which might be right for you.
How Mounjaro works
Mounjaro (tirzepatide) takes a dual-action approach. It mimics two hormones that regulate appetite and blood sugar, leading to reduced hunger and better blood sugar control. This dual hormone action can be particularly beneficial for people with type 2 diabetes.
How Wegovy works
Wegovy (semaglutide) works primarily by imitating a single hormone, GLP-1, which targets the areas of the brain involved in appetite regulation. This helps reduce hunger and calorie intake, supporting gradual, sustained weight loss. Wegovy is also used to manage type 2 diabetes.
See how the claim works →User experiences and effectiveness
Feedback highlights differing experiences with both medications. Some people report more significant weight loss with Mounjaro due to its dual hormone action, while others prefer Wegovy for a lower incidence of minor side effects such as nausea. Effectiveness varies based on individual factors including diet, exercise habits and metabolic health.
Potential side effects
Both medications carry possible side effects. Up to 1 in 10 users report mild symptoms such as nausea, gastrointestinal issues like diarrhoea or constipation, and headaches. It is important to discuss these risks with a healthcare provider and how they can be managed.
Is Mounjaro or Wegovy right for you?
Choosing between Mounjaro and Wegovy should be done with the guidance of a healthcare professional, taking into account your specific health needs, weight-loss goals, tolerance to side effects, and lifestyle. Our Irish-registered doctors assess all of this before recommending a treatment — or advising against one.
